Loading chat...
MS HB1666
Bill
Status
2/22/2023
Primary Sponsor
Angela Cockerham
Click for details
AI Summary
-
Appropriates $250,000 from the State General Fund to Jackson State University's College of Health Sciences for fiscal year 2024 (July 1, 2023 - June 30, 2024)
-
Requires the college to review and report on whether medications, treatments, and health care services available to Medicaid recipients with sickle cell disease are adequate to meet their needs
-
Mandates assessment of transitional care programs for emerging adults with sickle cell disease moving into adult care settings
-
Requires evaluation of emergency medical providers' training and preparedness to treat sickle cell patients experiencing vaso-occlusive crises, including adherence to validated protocols
-
Directs analysis of Medicaid reimbursement frameworks for sickle cell treatments, including drugs projected to be approved within five years, and whether current payment methodologies create access barriers for hospitals and patients
Legislative Description
Appropriation; JSU to conduct review and prepare report about health care services available to Medicaid recipients with sickle cell disease.
Last Action
Died In Committee
2/22/2023